Abk Biomedical Inc.

Abk Biomedical Inc. company information, Employees & Contact Information

Updated June 2026

Quick answer

Abk Biomedical Inc. is a Medical Equipment Manufacturing company and founded in 2012. It has approximately 40 employees on record. Contact data was last refreshed in June 2026. Find Abk Biomedical Inc.'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

Founded in 2012, we are focused on researching, developing, and commercializing breakthrough medical device therapies to improve treatment outcomes and the lives of patients with benign and malignant hypervascular tumors. With our multi-disciplinary experience in engineering, material science, oncology, medical science, regulatory, finance, business development, sales, marketing, and clinical study coordination we are staffed with the talent to drive the next level of technology for personalized healthcare in oncology.

Company Details

Employees
40
Founded
2012
Address
155 Chain Lake Dr, Unit 32,canada
Phone
(902) 442-4009
Email
in****@****cal.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Halifax, Nova Scotia
Looking for a particular Abk Biomedical Inc. employee's phone or email?

Abk Biomedical Inc. Questions

News

ABK Biomedical Raises US$35M in Series D Financing - PR Newswire

ABK Biomedical Raises US$35M in Series D Financing PR Newswire

ABK Biomedical raises $35 million USD to bring liver cancer treatment to market - BetaKit

ABK Biomedical raises $35 million USD to bring liver cancer treatment to market BetaKit

ABK Biomedical Announces FDA IDE Stage 2 Approval for Route90, a Prospective, Multi-Center, Pivotal Study of Eye90 microspheres® in unresectable Hepatocellular Cancer - PR Newswire

ABK Biomedical Announces FDA IDE Stage 2 Approval for Route90, a Prospective, Multi-Center, Pivotal Study of Eye90 microspheres® in unresectable Hepatocellular Cancer PR Newswire

ABK Biomedical announces that its Eye90 microspheres® device has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) - PR Newswire

ABK Biomedical announces that its Eye90 microspheres® device has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) PR Newswire

ABK Biomedical Raises USD 30M in Series C Financing - PR Newswire

ABK Biomedical Raises USD 30M in Series C Financing PR Newswire

ABK Biomedical announces FDA 510(k) clearance of Easi-Vue™ embolic microspheres for the embolization of arteriovenous malformations and hypervascular tumors - PR Newswire

ABK Biomedical announces FDA 510(k) clearance of Easi-Vue™ embolic microspheres for the embolization of arteriovenous malformations and hypervascular tumors PR Newswire

ABK Biomedical Raises $30M in Series B Financing - PR Newswire

ABK Biomedical Raises $30M in Series B Financing PR Newswire

Top Abk Biomedical Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant